|
|
Volumn 11, Issue 2, 2012, Pages 96-97
|
|
Trial watch: BTK inhibitor shows positive results in B cell malignancies
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BORTEZOMIB;
BRUTON TYROSINE KINASE;
PCI 32765;
PROTEIN TYROSINE KINASE INHIBITOR;
UNCLASSIFIED DRUG;
B CELL LYMPHOMA;
CHRONIC LYMPHATIC LEUKEMIA;
DRUG EFFICACY;
HUMAN;
LARGE CELL LYMPHOMA;
MANTLE CELL LYMPHOMA;
NOTE;
PRIORITY JOURNAL;
SIGNAL TRANSDUCTION;
TREATMENT RESPONSE;
ANTINEOPLASTIC AGENTS;
HUMANS;
LYMPHOMA, B-CELL;
PROTEIN-TYROSINE KINASES;
PYRAZOLES;
PYRIMIDINES;
|
|
EID: 84856461639
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd3656 Document Type: Note |
|
Times cited : (29)
|
|
References (0)
|
